» Articles » PMID: 35551213

Long Use of Continuous Positive Airway Pressure Protects Against the Development of Treatment-requiring Retinopathy of Prematurity

Overview
Journal Sci Rep
Specialty Science
Date 2022 May 13
PMID 35551213
Authors
Affiliations
Soon will be listed here.
Abstract

Although preterm infant mortality is low, the proportion of patients with treatment-requiring retinopathy of prematurity (TR-ROP) is high in Japan. Various multicenter studies have reported the risk factors for TR-ROP; however, no large-scale studies have been conducted in Japan. We retrospectively analyzed 13,645 infants born at < 28 weeks' gestation (January 1, 2009-December 31, 2018), and registered in the Neonatal Research Network of Japan database. TR-ROP was defined as ROP requiring retinal laser photocoagulation and/or intravitreal anti-vasoendothelial growth factor drugs. Multivariable logistic regression analysis was performed to identify factors associated with TR-ROP development. The median gestational age of enrolled infants was 26 weeks (interquartile range [IQR], 24-27 weeks), median birth weight was 760 g (IQR, 620-918 g). Proportion of patients with TR-ROP was 30.3%. TR-ROP was significantly associated with birth at < 26 weeks' gestational age (adjusted odds ratio [aOR] 1.54), blood transfusion (aOR 1.49), invasive ventilation ≥ 28 days (aOR 1.41), sepsis (aOR 1.29), birth weight < 750 g (aOR 1.28), intraventricular hemorrhage (aOR 1.33), delayed achievement of full enteral feeding > 14 days (aOR 1.28), and continuous positive airway pressure (CPAP) therapy ≥ 28 days (aOR 0.79). Supplemental oxygen ≥ 28 days was not associated with TR-ROP development. Lower gestational age at birth and birth weight, blood transfusion, prolonged invasive ventilation, sepsis, intraventricular hemorrhage, and delayed achievement of full enteral feeding were risk factors for TR-ROP, whereas CPAP use was protective against TR-ROP.

Citing Articles

Prospective epigenome and transcriptome analyses of cord and peripheral blood from preterm infants at risk of bronchopulmonary dysplasia.

Cho H, Wang X, Campbell M, Panduri V, Coviello S, Caballero M Sci Rep. 2023; 13(1):12262.

PMID: 37507442 PMC: 10382533. DOI: 10.1038/s41598-023-39313-0.


Modifiable Risk Factors and Preventative Strategies for Severe Retinopathy of Prematurity.

Prasad M, Ingolfsland E, Christiansen S Life (Basel). 2023; 13(5).

PMID: 37240719 PMC: 10224242. DOI: 10.3390/life13051075.


Clinical feature and predictive factor analysis for spontaneous regression of retinopathy of prematurity in a Chinese population.

Li Y, Zhou X, Cai X, Yang C Int J Ophthalmol. 2022; 15(12):1978-1984.

PMID: 36536972 PMC: 9729098. DOI: 10.18240/ijo.2022.12.13.

References
1.
Tin W, Milligan D, Pennefather P, Hey E . Pulse oximetry, severe retinopathy, and outcome at one year in babies of less than 28 weeks gestation. Arch Dis Child Fetal Neonatal Ed. 2001; 84(2):F106-10. PMC: 1721225. DOI: 10.1136/fn.84.2.f106. View

2.
Zin A, Gole G . Retinopathy of prematurity-incidence today. Clin Perinatol. 2013; 40(2):185-200. DOI: 10.1016/j.clp.2013.02.001. View

3.
Adams G, Bunce C, Xing W, Butler L, Long V, Reddy A . Treatment trends for retinopathy of prematurity in the UK: active surveillance study of infants at risk. BMJ Open. 2017; 7(3):e013366. PMC: 5372114. DOI: 10.1136/bmjopen-2016-013366. View

4.
Tavassoli S, Wach R, Haynes R, Markham R, Williams C . Estimate of incidence of ROP requiring treatment in extreme preterms and impact on service-7 year review in tertiary unit. Eye (Lond). 2019; 33(5):845-849. PMC: 6707198. DOI: 10.1038/s41433-018-0330-x. View

5.
Miller M, Carlo W, Martin R . Continuous positive airway pressure selectively reduces obstructive apnea in preterm infants. J Pediatr. 1985; 106(1):91-4. DOI: 10.1016/s0022-3476(85)80475-3. View